Mycobacterium fortuitum - Drug effects
Research News and Information

Monday, November 23, 2009

Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.

19 Jan 2009 BACKGROUND: In view of the problems of correlation between the data provided by classical microbiological studies and clinical response, we designed an in vitro method to screen for the sterilizing activity of various antibiotics, individually or in ... Read more...

[Microbiological properties of M. porcinum isolated from a patient with impairments in IL-12/IFN-gamma pathway]

30 Oct 2008 PURPOSE: Mycobacterium porcinum has been successfully isolated from the patient with abnormal signal transduction pathway of IL12/IFN-gamma. The properties of each bacterium were determined by conventional identification methods, DNA sequencing ... Read more...

[Clinical features of pulmonary disease caused by Mycobacterium fortuitum]

29 Sep 2008 We analyzed clinical and microbiological features of six cases involving Mycobacterium fortuitum isolated from sputum or surgical lung specimen. Patients were five men and one woman with an average age of 59. Four cases had a history of pulmonary ... Read more...

Latest indexed articles for 'Mycobacterium fortuitum - Drug effects'

These are the very latest articles for this heading:

• Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth. 19 Jan 2009
• [Microbiological properties of M. porcinum isolated from a patient with impairments in IL-12/IFN-gamma pathway] 30 Oct 2008
• [Clinical features of pulmonary disease caused by Mycobacterium fortuitum] 29 Sep 2008
• Synthesis and studies on antibacterial activity of pyrido[3,2-e]-1,2-thiazines and related derivatives. 30 Aug 2008
• Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria. 29 Jun 2008
• Transcriptional analysis of Mycobacterium fortuitum cultures upon hydrogen peroxide treatment using the novel standard rrnA-P1. 17 Jun 2008
• Antimycobacterial polyacetylenes from Levisticum officinale. 29 Apr 2008
• [Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection] 28 Feb 2008
• [Hixozide, a novel combined antituberculosis preparation] 30 Dec 2007
• Pyrido-1,2-thiazines and their in vitro antibacterial evaluation. 30 Dec 2007
• [Susceptibility to antimicrobial agents of rapidly growing mycobacteria] 29 Nov 2007
• Antimicrobial lexitropsins containing amide, amidine, and alkene linking groups. 24 Oct 2007
• Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin. 29 Sep 2007
• In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. 10 Mar 2007
• Effects of glutathione and N-acetyl cysteine on the antimycobacterial efficacy of isoniazid on Mycobacterium fortuitum in vitro. 29 Nov 2006
• In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. 30 Sep 2006
• [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria] 29 Sep 2006
• Novel streptomycin resistance gene from Mycobacterium fortuitum. 3 Sep 2006
• Successful treatment of a widespread cutaneous Mycobacterium fortuitum infection with levofloxacin. 30 Aug 2006
• Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors. 22 Aug 2006

See a longer list of these articles.

Technical information about 'Mycobacterium fortuitum'

Definition: A rapid-growing, nonphotochromogenic species that is potentially pathogenic, producing lesions of lung, bone, or soft tissue following trauma. It has been found in soil and in injection sites of humans, cattle, and cold-blooded animals. (Dorland, 28th ed)

Descriptor UI: D019907

Alternative terms: Mycobacterium fortuitum;

Allowable Qualifiers: classification; cytology; drug effects; enzymology; genetics; growth & development; immunology; isolation & purification; metabolism; pathogenicity; physiology; radiation effects; ultrastructure; chemistry; virology;

Tree Number: B03.510.024.049.525.500.250.325; B03.510.460.400.410.552.552.250.325;

History Note: 98

Technical Notes: infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL (IM); DF: MYCOBACT FORTUITUM